Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital
HUM's CenterWell venture with BlackRock brings $2.8 billion in capital, easing balance sheet liabilities and supporting clinic expansion.
Zacks Investment Research10/14/2026Positive
HUM
Humana IncNYSEHEALTHCAREHEALTHCARE PLANS
Key Statistics
Market Cap
$49.61B
P/E Ratio
39.05
EPS
$10.58
Beta
0.74
52W High
$456.50
52W Low
$161.90
50-Day MA
$393.00
200-Day MA
$300.29
Dividend Yield
0.82%
Profit Margin
0.88%
Forward P/E
24.33
PEG Ratio
1.25
About Humana Inc
Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.
Fundamentals
| Revenue (TTM) | $145.68B |
| Gross Profit (TTM) | $19.89B |
| EBITDA | $3.60B |
| Operating Margin | 3.46% |
| Return on Equity | 6.89% |
| Return on Assets | 3.90% |
| Revenue/Share (TTM) | $1211.44 |
| Book Value | $160.00 |
| Price-to-Book | 2.34 |
| Price-to-Sales (TTM) | 0.34 |
| EV/Revenue | 0.388 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 27.10% |
| Quarterly Revenue Growth (YoY) | 26.20% |
| Shares Outstanding | $120.08M |
| Float | $119.83M |
| % Insiders | 0.21% |
| % Institutions | 102.01% |
Historical Volatility
HV 10-Day
69.99%
HV 20-Day
53.89%
HV 30-Day
46.15%
HV 60-Day
41.01%
HV Rank
69.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($465.12 target)
2
Strong Buy11
Buy12
Hold1
SellLatest News
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
PRNewsWire10/13/2026Neutral
Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2026 (3Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 6, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 3Q26 earnings call may be accessed via Humana's Investor Relations page at.
Business Wire10/12/2026Neutral
Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength?
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks Investment Research10/12/2026Positive
Humana Hits 95% Four-Star Coverage: What it Means for HUM
Humana's 2027 Medicare Advantage ratings rebound puts 95% of members in four-star or better plans, potentially boosting 2028 bonus payments and plan benefits.
Zacks Investment Research10/12/2026Positive
DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test
DataMeds AI, Inc. (NASDAQ:MEDS) shares are up on Monday as traders react to Medicaid coverage policy news tied to the company's Helomics business and its ChemoFx assay.
Benzinga10/12/2026Positive
Humana Surges On 2027 CMS Ratings, Technical Breakout, Shares Fairly Priced
Humana surged after its main Medicare Advantage contract regained a 4-star CMS rating for 2027, a major profit catalyst. 95% of HUM's Medicare Advantage members will be in 4-star plans, unlocking a 5% benchmark rate advantage and supporting a robust earnings outlook. I maintain a "Hold" rating as shares appear fairly valued post-rally, despite strong fundamentals, a technical breakout, and likely further sell-side upgrades.
Seeking Alpha10/9/2026Positive
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
UNH's diversified healthcare platform, improving Medicare Advantage profitability and lower valuation give it an edge over HUM.
Zacks Investment Research10/9/2026Positive
Seniors Face an 18% Drop in Highly Rated Medicare Advantage Plans — But Quality Might Not Be the Cause
Healthcare spending can keep growing while the companies providing coverage struggle to turn that growth into profits. For investors, the difference is important: government reimbursement, medical bills, and regulatory decisions all influence how much revenue reaches the bottom line.
24/7 Wall Street10/9/2026Positive
Humana Stock Jumps on Raised Medicare Advantage Ratings
Humana shares are soaring after the health insurer said it received improved star ratings for a number of its Medicare Advantage plans.
Investopedia10/9/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HUM and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 10/17/2026